Keywords
quality of life
electronic system HESA
clinical practice
How to Cite
Keywords
Abstract
BACKGROUND. Over the past years, digital technologies have been increasingly used worldwide for monitoring patient-reported assessment data in real-world clinical practice. Electronic systems allow to automatically assess a patient’s perception of disease and therapy in a convenient mode, remotely, and with obvious savings in time and resources.
AIM. To develop and test the domestic electronic system for monitoring the health status of patients with hematologic malignancies based on their quality-of-life data.
MATERIALS & METHODS. At the first stage, the electronic system was developed on the basis of a secure internet resource using two special questionnaires HM-PRO and HADS. Patients with hematologic tumors completed electronic questionnaires on admission to the hospital, after treatment, and remotely at different times after discharge. The data was processed by descriptive statistics.
RESULTS. The interactive electronic system “Health – Electronic Self-Assessment” (HESA) was developed so that a graphic representation of the patient-reported real-time questionnaire data is provided for both patients and doctors. The testing of HESA included 115 patients (the mean age of 44 years; 63 women) with various hematologic tumors treated with high-technology medical services. Half of the patients completed the questionnaires remotely at different times after hospital discharge. Using HESA, clinicians were able to remotely monitor the changes in various quality-of-life aspects and psychological issues relying on diagrams, summary results, and patients’ comments.
CONCLUSION. The first domestic electronic system HESA was developed for monitoring the health status of oncohematologic patients based on their quality-of-life data. We have shown that HESA can well be regarded as a valuable tool to inform hematologists on the state of their patients during hospitalization and most importantly during remote follow-up after discharge. It can contribute to further promotion of the patient-oriented approach in medicine and improvement of medical care quality for one of the most challenging categories of oncohematologic patients.
References
- Новик А.А., Ионова Т.И. Исследование качества жизни в онкогематологии. Клиническая онкогематология. 2008;1(2):168–73. [Novik A.A., Ionova T.I. The study of quality of life in oncohematology. Klinicheskaya onkogematologiya. 2008;1(2):168–73. (In Russ)]
- Ионова Т.И., Салек С., Олива Е. Значение оценок, данных пациентом, в онкогематологии. Клиническая онкогематология. 2014;7(4):573–6. [Ionova T.I., Salek S., Oliva E. Value of Patient-Reported Outcomes in Oncohematology. Klinicheskaya onkogematologiya. 2014;7(4):573–6. (In Russ)]
- Goswami P, Oliva E, Ionova T, et al. Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study. Ther Adv Hematol. 2020;11:1–14. doi: 10.1177/2040620720955002.
- Snyder CF, Aaronson NK, Choucair AK, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305–14. doi: 10.1007/s11136-011-0054-x.
- Chan EKH, Edwards TC, Haywood K, et al. Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user’s guide. Qual Life Res. 2019;28(3):621–7. doi: 10.1007/s11136-018-2048-4.
- Efficace F, Gaidano G, Lo-Coco F. Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice? Blood. 2017;130(7):859–66. doi: 10.1182/blood-2017-03-737403.
- Efficace F, Cottone F. Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemia. Expert Rev Hematol. 2019;12(1):1–3. doi: 10.1080/17474086.2019.1547189.
- Lehmann J, Buhl P, Giesinger J, et al. Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal. J Med Internet Res. 2021;23(6):e26022 doi: 10.2196/26022.
- Girgis A, Durcinoska I, Arnold A, et al. Web-Based Patient-Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care): Multicenter Pragmatic Nonrandomized Trial. J Med Internet Res. 2020;29;22(10):e19685. doi: 10.2196/19685.
- Basch E, Mody GN, Dueck AC. Electronic patient-reported outcomes as digital therapeutics to improve cancer outcomes. JCO Oncol Pract. 2020;16(9):541–2. doi: 10.1200/OP.20.00264.
- Van den Hurk CJG, Mols F, Eicher M, et al. A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring. Curr Oncol. 2022;29(6):4370–85. doi: 10.3390/curroncol29060349.
- Meirte J, Hellemans N, Anthonissen M, et al. Benefits and Disadvantages of Electronic Patient-reported Outcome Measures: Systematic Review. JMIR Perioper Med. 2020;3(1):e15588. doi: 10.2196/15588.
- Никитина Т.П., Ефремов С.М., Мельниченко В.Я. и др. Использование цифровых технологий для мониторинга состояния пациента и его качества жизни. Гематология. Трансфузиология. Восточная Европа. 2023;9(3):341–56. doi: 10.34883/PI.2023.9.3.001. [Nikitina T.P., Efremov S.M., Melnichenko V.Ya., et al. Using Digital Technologies for Monitoring Patient’s Well-Being and Quality of Life. Hematology. Transfusiology. Eastern Europe. 2023;9(3):341–56. doi: 10.34883/PI.2023.9.3.001. (In Russ)]
- Ramos-Cillan S, Barreras Ruiz N, Pascual A, et al. Feasibility of Electronic Patient-Reported Outcome (ePRO) Measurement Using PRO-CTCAE® Questionnaire to Improve Quality of Life Assessment and Healthcare Resources Management in Patients with Lymphoma Receiving Intravenous Chemotherapy. Blood. 2022;140(1):10987–8. doi: 10.1182/blood-2022-157481.
- Efficace F, Luppi M, Potenza L, et al. Patients’ Perception of Usability and Utility of a Digital Health Tool for Electronic Patient-Reported Outcomes Monitoring in Real-Life Hematology Practice: Evidence from the Gimema-Alliance Platform. Blood. 2023;142(1):3714. doi: 10.1182/blood-2023-180574.
- Jagannath S, Mikhael J, Nadeem O, Raje N. Digital Health for Patients With Multiple Myeloma: An Unmet Need. JCO Clin Cancer Inform. 2021;5:1096–105. doi: 10.1200/CCI.20.00145.
- Buzaglo J, Stepanski E, Joiner M, et al. Using an ePRO tool to help meet quality metrics in a clinical oncology practice. J Clin Oncol. 2019;37(27_suppl):171. doi: 10.1200/JCO.2019.37.27_suppl.171.
- Rocque GB. Learning From Real-world Implementation of Daily Home-Based Symptom Monitoring in Patients With Cancer. JAMA Netw Open. 2022;5(3):e221090. doi: 10.1001/jamanetworkopen.2022.1090.
- Efficace F, Patriarca A, Luppi M, et al. Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform. Front Oncol. 2022;12:826040. doi: 10.3389/fonc.2022.826040.
- McKelvey BA, Berk A, Chinet L, et al. A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets. JCO Clin Cancer Inform. 2023;7:e2200161. doi: 10.1200/CCI.22.00161.
- Efficace F, Breccia M, Fazi P, et al. The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study. JMIR Res Protoc. 2021;10(6):e25271. doi: 10.2196/25271.
- Goswami P, Oliva E, Ionova T, et al. Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study. J Comp Eff Res. 2019;8(7):523–33. doi: 10.2217/cer-2018-0108.
- Ионова Т.И., Банникова А.Е., Быкова А.В. и др. Апробация и валидация русской версии специального опросника HM-PRO для оценки качества жизни у пациентов с онкогематологическими заболеваниями в реальной клинической практике. Вестник Межнационального центра исследования качества жизни. 2020;35–36:86–104. [Ionova T.I., Bannikova A.E., Bykova A.V., et al. Testing and validation of the Russian version of the HM-PRO quality of life questionnaire for oncohematologic patients in real clinical practice. Vestnik Mezhnatsionalnogo tsentra issledovaniya kachestva zhizni. 2020;35–36:86–104. (In Russ)]
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
- Nakano J, Fukushima T, Tanaka K, et al. Anxiety, depression, physical symptoms, and activity in patients with hematological malignancy undergoing chemotherapy: A cross-sectional study. Int Med Care. 2019;3:2–6. doi: 10.15761/IMC.1000130.
- Garcia LC, Cillan SR, Garcia AL, et al. Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy. Blood. 2022;140(1):5164–6. doi: 10.1182/blood-2022-159076.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2024 Clinical Oncohematology